topicProbiotic Blood Pressure Meta-Analysis
claimBackground Metabolically dysfunction-associated steatotic liver disease (MASLD) is a growing public health challenge linked to obesity and metabolic dysregulation.
evidence level1
citationJurek JM (2026)
sourceEffects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026).
topicProbiotic Blood Pressure Meta-Analysis
claimObjective This updated systematic review aims to evaluate evidence from randomized controlled trials (RCTs) regarding the effects of specific animal-based foods on metabolic, hepatic, and anthropometric outcomes in adults with MASLD.
evidence level1
citationJurek JM (2026)
sourceEffects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026).
topicProbiotic Blood Pressure Meta-Analysis
claimThe evidence is limited by small sample sizes in specific food categories and variability in dietary assessment methods.
evidence level1
citationJurek JM (2026)
sourceEffects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026).
topicProbiotic Blood Pressure Meta-Analysis
claimSince pharmacological options are limited, Mediterranean (MED) and DASH patterns are recommended.
evidence level1
citationJurek JM (2026)
sourceEffects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026).
topicProbiotic Blood Pressure Meta-Analysis
claimTrial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions.
evidence level1
citationZhong Y (2026)
sourceEffects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis.
topicProbiotic Blood Pressure Meta-Analysis
claimConclusion Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events.
evidence level1
citationZhong Y (2026)
sourceEffects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis.
topicProbiotic Blood Pressure Meta-Analysis
claimObjective This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety.
evidence level1
citationZhong Y (2026)
sourceEffects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis.
topicProbiotic Blood Pressure Meta-Analysis
claimMethods A systematic search was conducted across five English-language databases: PubMed, Embase, Cochrane Library, Web of Science, and MEDLINE.
evidence level1
citationZhong Y (2026)
sourceEffects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis.